全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 2196183-71-6 | Benzydamine EP Impurity B;3-((1,5-Dibenzyl-1H-indazol-3-yl)oxy)-N,N-dimethylpropan-1-amine hydrochloride | C26H30ClN3O |
| 2196185-65-4 | Benzydamine Impurity 1;3-Dimethylaminopropyl 2-benzylaminobenzoate hydrochloride | C19H25ClN2O2 |
| 2197414-56-3 | Lenalidomide N-Formyl Impurity;Formyl Lenalidomide;N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]formamide | C14H13N3O4 |
| 2197420-75-8 | Lenalidomide Impurity 2;5-amino-2-(7-amino-3-oxo-1H-isoindol-2-yl)-5-oxopentanoic acid | C13H15N3O4 |
| 2200269-28-7 | Cinacalcet Impurity 17;[(1R)-1-(naphthalen-2-yl)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine hydrochloride | C22H23ClF3N |
| 2201839-83-8 | 4-(2-Acetyl-5-chlorophenyl)-5-methoxypyridin-2(1H)-one | C14H12ClNO3 |
| 2204863-06-7 | Palbociclib Impurity 2;8-cyclopentyl-5-Methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)aMino)-6-vinylpyrido[2,3-d]pyriMidin-7(8H)-one | C24H29N7O |
| 2206736-04-9 | 2-[(2S)-4-[7-(8-methylnaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-prop-2-enoylpiperazin-2-yl]acetonitrile | C33H39N7O2 |
| 2206827-12-3 | Pape-ethyl carbamate;ethyl N-[4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl]carbamate | C16H17N3O4 |
| 2206827-14-5 | Sorafenib impurity 10;propan-2-yl N-[4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl]carbamate | C17H19N3O4 |
| 2211054-90-7 | Macitentan Impurity 2;2,2'-[Ethane-1,2-diylbis(oxy)]bis(5-bromopyrimidine) | C10H8Br2N4O2 |
| 2212020-52-3 | Orforglipron;3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one | C48H48F2N10O5 |
| 2212021-56-0 | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate;tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1-carboxylate | C12H18N2O3 |
| 2212021-59-3 | tert-Butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate;2-Methyl-2-propanyl (4S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | C20H27FN4O2 |
| 2212021-61-7 | tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | C23H28FN5O3 |
| 2212021-83-3 | 5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid;5-[(4S)-2,2-dimethyloxan-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)cyclopropyl]indole-2-carboxylic acid | C22H25N3O5 |
| 2212022-57-4 | (S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one hydrochloride;1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methylindazol-5-yl)imidazol-2-one;hydrochloride | C26H26ClF2N7O |
| 2213398-75-3 | Ibrutinib Impurity 7;1-methyl-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-amine | C18H15N5O |
| 2216750-52-4 | Solifenacin EP Impurity D;[(1R)-1-phenyl-3,4-dihydro-1H-isoquinolin-2-yl]-[(1S)-1-phenyl-3,4-dihydro-1H-isoquinolin-2-yl]methanone | C31H28N2O |
| 2217657-09-3 | 1-(tert-Butyl)-3-chloronaphthalene | C14H15Cl |
| 2217657-10-6 | 2-(4-(tert-Butyl)naphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C20H27BO2 |
| 2221812-26-4 | 2-(6-Bromo-2,3-dichlorophenyl)-1,3-dioxolane | C9H7BrCl2O2 |
| 2222114-22-7 | Thalidomide-Piperazine 5-fluoride;2-(2,6-Dioxopiperidin-3-yl)-5-fluoro-6-(piperazin-1-yl)isoindoline-1,3-dione | C17H17FN4O4 |
| 2222690-89-1 | MorDalphos Pd G3;(2-(Di-1-adamantylphosphino)morpholinobenzene)[2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate, Mesyl(2-(di-1-adamantylphosphino)morpholinobenzene)[2-(2'-amino-1,1'-biphenyl)]palladium(II),, MorDalphos-G3-palladacycle | C43H55N2O4PPdS |
| 2222941-37-7 | Inobrodib;(6S)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one | C30H32F2N4O3 |
| 2222970-00-3 | 2-Bromo-9,9-dimethyl-5-phenyl-9H-fluorene | C21H17Br |
| 2225909-61-3 | 8-Bromo-1-chlorodibenzo[b,d]furan | C12H6BrClO |
| 2226413-61-0 | Rosuvastatin EP Impurity E;(3R,5S,E)-7-(4-(4-Fluorophenyl)-2-(2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-2-hydroxy-N-methylethylsulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid | C38H46F2N6O9S2 |
| 2226413-62-1 | Rosuvastatin EP Impurity J;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[[(E)-2-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]ethenyl]sulfonyl-methylamino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid | C38H44F2N6O8S2 |
| 2226517-76-4 | Sgc-gak-1;6-bromo-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine | C18H17BrN2O3 |
| 2226735-55-1 | (S)-6-(4-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile | C20H18F2N6O |
| 2227199-17-7 | (S)-3-(Trifluoromethoxy)pyrrolidine hydrochloride | C5H9ClF3NO |
| 2227206-03-1 | 1-(5-Methylpyrazin-2-yl)methanamine dihydrochloride;(5-methylpyrazin-2-yl)methanamine;dihydrochloride | C6H11Cl2N3 |
| 2227252-55-1 | 2-[(4S)-1-[Tert-butoxy)carbonyl]-3,3-difluoropiperidin-4-yl]acetic acid | C12H19F2NO4 |
| 2227741-18-4 | (3S)-3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-3-hydroxypropanoic acid | C13H23NO5 |
| 2229714-16-1 | (S)-3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione benzenesulfonate | C23H26N4O6S |
| 2229864-78-0 | 1-(3-Bromophenyl)dibenzo[b,d]furan | C18H11BrO |
| 2230198-02-2 | Danuglipron;2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid | C31H30FN5O4 |
| 2230200-74-3 | Methyl (S)-4-amino-3-((oxetan-2-ylmethyl)amino)benzoate | C12H16N2O3 |
| 2230200-76-5 | methyl 2-(chloromethyl)-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylate | C14H15ClN2O3 |
| 2230475-63-3 | Kdm4-IN-4;(1R,2S,3R,4S)-3-[(dimethylamino)methyl]-1-phenylbicyclo[2.2.1]heptan-2-ol | C16H23NO |
| 2230697-41-1 | NRF2 activator-1;ethyl (3S)-3-(7-methoxy-1-methylbenzotriazol-5-yl)-3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1?6,2-benzoxathiazepin-2-yl]methyl]phenyl]propanoate | C30H34N4O6S |
| 2230788-58-4 | meCgPPh Pd G3;[(1,3,5,7-Tetramethyl-6-phenyl-2,4,6-trioxa-6-phosphaadamantane)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate | C29H34NO6PPdS |
| 2230788-63-1 | TrixiePhos Pd G3;Mesyl(2-(di-tert-butylphosphino)-1,1'-binaphthyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) | C41H44NO3PPdS |
| 2230788-66-4 | [4-[2-[bis(tricyclo[3.3.1.13,7]dec-1-yl)phosphino-κP]phenyl]morpholine](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium | C44H57N2O4PPdS |
| 2230788-67-5 | Mesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-amino-1,1'-biphenyl)]palladium(II);cataCXium Pd G4 | C38H54NO3PPdS |
| 2230800-88-9 | Eltrombopag Impurity 40;methyl 3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate | C14H13NO3 |
| 2230836-55-0 | N-((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)-7-methoxy-2-methyl-6-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine | C26H41P |
| 2230840-12-5 | 7-methoxy-2-methyl-6-[(3S)-oxolan-3-yl]oxy-6H-quinazolin-4-one | C14H16N2O4 |
| 2230840-47-6 | (R)-1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride;(1R)-1-[3-nitro-5-(trifluoromethyl)phenyl]ethanamine;hydrochloride | C9H10ClF3N2O2 |